In addition, Cha et al. [3] shed light on the molecular mechanisms regulating ANO1 by androgens, affirming its involvement in benign prostatic hyperplasia (BPH) and cancer through testosterone-driven pathways, which further reinforces the idea that TMEM16A is crucial in prostate-related disorders [3]. This evidence concerns the gene ANO1 and benign prostatic hyperplasia.